Neoadjuvant chemotherapy is associated with improved outcomes in patients with stage 1A and 1B pancreatic cancer undergoing surgery: An NCDB study

Authors

Noah Rozich, Advocate Aurora HealthFollow
Maharaj Singh, Advocate Aurora HealthFollow
Isaac Kriley, Advocate Aurora HealthFollow
James Weese, Advocate Aurora HealthFollow
Aaron H. Chevinsky, Advocate Aurora HealthFollow
Wesley Papenfuss, Advocate Aurora HealthFollow
Geoffrey Bellini, Advocate Aurora HealthFollow

Recommended Citation

Rozich N, Singh M, Kriley I, et al. Neoadjuvant chemotherapy is associated with improved outcomes in patients with stage 1A and 1B pancreatic cancer undergoing surgery: An NCDB study. Journal of Clinical Oncology. 2022;40(16_suppl):4157.

Affiliations

Aurora St. Luke's Medical Center

Advocate Aurora Research Institute

Advocate Aurora Health

Aurora Cancer Care

Aurora Health Care

Type

Abstract